chrisvoncsefalvay/vaers-outcomes huggingface dataset:
doses administered after more than 1 temperature excursion; doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 2:50 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Feb-2021 at 2:50 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.    Vials only punctured right before administration.  No treatment medication was provided.   This case was linked to MOD-2022-566976 (Patient Link).
Testing positive for Covid 19; Testing positive for Covid 19; This is a spontaneous report. A contactable consumer (patient) reported for himself.  A male patient of an unspecified age received bnt162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date patient experienced testing positive for covid 19, testing positive for covid 19. He reported I'm hoping this gets to a research assistant in your Vaccine Dept. I am currently on Home Quarantine after Testing positive for Covid 19. I'm a Cardiologist. I received both doses of Pfizer Vaccine starting before Xmas. If you would be interested in My lot numbers, Hx (history) or blood samples feel free to contact me. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. The outcome for both events was unknown  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt developed vomiting and paleness of approximately 30 minutes after vaccines administration that persisted for approximately 6 hours. No fever, no rash, no hives, no seizures, no diarrhea or other complaints. Advised to consult PCP and/or ER -> next day mother reports no problems & no medical follow-up.
Client was given a Tdap on 2/6/09 and 9/14/09
experienced soreness  at the injection and states that "if I push on it, it is still there"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (experienced soreness  at the injection and states that "if I push on it, it is still there") in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (experienced soreness  at the injection and states that "if I push on it, it is still there"). At the time of the report, VACCINATION SITE PAIN (experienced soreness  at the injection and states that "if I push on it, it is still there") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Pt had slight fever, doctor recommended Tylenol but was not able to control it then doctor advised combination of Motrin and Tylenol and did not help either. Also tried cold shower, Mother also noticed that right jaw line was swollen and sticking out so face looked deformed, jaw problems lasted for 2 days. Pt also had bad headaches. Patient then noticed personality changes, pt did not want to play as usual would just sit at the corner, did not have fever at this time. For 2 weeks pt woke up screaming at not and would hallucinate, seeing things crawl up father, etc, PT did not have fever at this time. A nurse, friend of the family, observed white measle like bumps on throat, child was taken to doctor again.
Red rash: raised, hot to touch, itchy. 5mm long, 2mm wide.
ANTIBODY LEVELS ABNORMAL; TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On MAR-2021, the patient experienced tired. On SEP-2021, the patient experienced antibody levels abnormal. Laboratory data included: Antibody test (NR: 1 - 10) Low (1.2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the antibody levels abnormal and tired was not reported. This report was non-serious.; Sender's Comments: V0 :  Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Fainting, shortness of breath, pale, sweating. Treatment: EPIPEN 0.3mg.
One day later he developed warm erythema in the right thigh, around injection site.  By day 2 it had grown in size and he was treated for mild cellulitis with Keflex (5-7 day course).  No fevers or other symptoms.
I have one Moderna and one Pfizer in me so far; I have one Moderna and one Pfizer in me so far; No Adverse Event; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (I have one Moderna and one Pfizer in me so far), COVID-19 IMMUNISATION (I have one Moderna and one Pfizer in me so far) and NO ADVERSE EVENT (No Adverse Event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (I have one Moderna and one Pfizer in me so far), COVID-19 IMMUNISATION (I have one Moderna and one Pfizer in me so far) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (I have one Moderna and one Pfizer in me so far), COVID-19 IMMUNISATION (I have one Moderna and one Pfizer in me so far) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.            Concomitant medications were not reported.  The patient had took one Moderna and one Pfizer so far and wanted trifecta with Johnson and Johnson. So patient wanted to know whether patient could take a third dose.  No treatment information was provided by the reporter.  This case was identified as part of retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Nov2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 18Jan2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 74 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), in left arm, as dose 2, single (Batch/Lot number: unknown), in left arm and on 16May2022 at 12:00 as dose 5 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Migraines" (unspecified if ongoing); "sleep apnea" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient received Moderna vaccine booster. While in observation, five minutes later the patient passed out. B/P was 94/65, HR 40 , R 10. After observing the patient, he was fine and stated he has a Hx of passing out after drawing blood. Patient was released from site.
About 3 days later, I started noticing shortness of breath. Mine had just caused really bad allergies. I thought it was just my allergies causing the shortness of breath. After my allergies stopped for the season, I was still having shortness of breath. About a week or two after getting my vaccine I started noticing that my dizzy spells started getting worse. I was having light headedness. I was having these beforehand, but after the vaccine they were worse. I would normally just get a little head rush (like standing up too fast), but now my vision starts getting black from the outside coming in. I almost pass out. After about 3-5 seconds, I'm able to gather myself and keep myself from passing out. I also noticed that my heart cannot take as much strain as it used to. I was having palpitations. It feels like it's attempting to stop beating. It now is triggered more easily. It's very hard for me to catch my breath and I get worn out super easily. I went and saw my PCP about 2 weeks ago for a regular routine visit and I informed her about my symptoms. She said everything looked fine and in normal ranges. They sent records to a pap specialist. I am still waiting to hear back from them to do some testing. I also talked with my therapist about some of the issues I've had because we thought it might be anxiety related, but we ruled that out. It is more medical.
Experiencing a side effect in his skin; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Experiencing a side effect in his skin) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Experiencing a side effect in his skin). At the time of the report, IMMUNISATION REACTION (Experiencing a side effect in his skin) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant drug information was provided.  Patient was not a clinical trial participant from Moderna. It was reported that during the pandemic patient received the Moderna vaccine and experienced side effects in the skin.   Treatment medication information was not provided.
Information has been received from a licensed practical nurse concerning a 47 year old male patient who approximately 20-JUN-2012 was vaccinated IM with a 0.5 ml of a single dose of PNEUMOVAX 23 (lot # 672673/0492AE; Exp date: 22-AUG-2013). The patient was taking unspecified medications for pain and stomach acid as well as muscle relaxers. On approximately 20-JUN-2012, within the last week, the patient experienced cough after vaccination. It was unknown if the patient sought medical attention. Subsequently, on an unspecified date, the patient recovered from cough after vaccination. This is one of several reports received from the same source. Additional information has been requested.
inflammation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program.  An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Allergy" (ongoing); "Heterozygous Factor V Leiden " (unspecified if ongoing); "psoriatic arthritis " (unspecified if ongoing). Concomitant medication(s) included: HUMIRA taken for psoriatic arthropathy. Past drug history included: Warfarin for Heterozygous Factor V Leiden ; adalimumab (HUMIRA) for psoriatic arthritis , notes: it worked; however, had to come on and off Humira a couple times due to unspecified surgery and other issues. Vaccination history included: BNT162B2 (Dose 1), for COVID-19 immunisation, reaction(s): "developed swelling in his normal arthritic area". The following information was reported: INFLAMMATION (non-serious), outcome "unknown", described as "inflammation". Therapeutic measures were taken as a result of inflammation.  Additional Information: The patient stated when he received his first Pfizer COVID vaccine, he developed swelling in his normal arthritic area. After his second shot, he developed inflammation and then the Humira stopped working. Due to this, patient saw his rheumatologist a month or so later. The rheumatologist reported that she confirmed that a lot of people were having problems with inflammation after the vaccine, even with new patients. They were doing this thing where they put you on prednisone (MANUFACTURER UNKNOWN) for a bit and start you up again. The patient tried the aforementioned regimen, but it was not effective. No co-suspect medications were reported.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
share experience of one of the side effects; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (share experience of one of the side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (share experience of one of the side effects). At the time of the report, IMMUNISATION REACTION (share experience of one of the side effects) outcome was unknown.            It was reported that patient received second booster dose. Concomitant medications were not reported. Treatment medications were not provided.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis. Previously administered products included ZOSTAVAX. Concurrent medical conditions included allergy to antibiotic (Sulfa antibiotics), drug hypersensitivity (to neomycin) and iodine allergy. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced a sore arm after receiving a flu vaccine (unknown manufacturer). This case has been linked with US2019087226, reported by same reporter for the same patient. It was unknown whether VAERS information reported for Flu vaccine or not.
pt recv vax 19MAR97 & 11JUN97 pt devel a chickenpox eruption w/minimal itching & less than 50 lesions;pt recovered;
Client woke on 3/18/21 in AM to go to Bathroom.  While client was walking to her residential bathroom. Client stated to writer she fainted 3 times and Husband had to help her.
5 days after injection, I had severe light headedness & balance problems, lasting 6 hrs on 10/19. On 10/20, had light diarrhea. On 10/22, had servere gas & diarrhea; took Lomotal to stop it. On 10/23, got up, felt fine, no problems. Follow-up indicates pt had the flu for 3 weeks over Christmas and New Years. Now, still not over it, starting with sore throat and aches in my joints about 4/11/00.
I got home from a trip and started to feel like I had a cold. I had a cough, a headache and my nose was running like crazy. I couldn't stop coughing. I saw a friend of mine and she told me to contact the doctor, so I did. I went to the doctor's office the next day and they tested for the Flu and Covid virus. I tested positive for Covid-19 on 11/17. I was given a prescription for PAXLOVID. I started taking it the same day I tested and I started to feel so much better the very next day.
Patient got her 2nd  Shingrix shot on Saturday afternoon around 4pm and her arm started hurting at 7:30. It bacame really badly inflammed arounf tje injection site on Sunday. She had a fever of 100.2 and her arm muscle had a knot in it. It was warm and red. On that Tuesday she went to see a DR and he prescribed an antibiotic for her to take. She was not able to work her regular shift on Monday
Parents state child was crying constantly & temp was 103.5R mom doesn't know if they subtracted a degree; MD states viral infect;
I had tingling upper left lip. It began to swell, red of the lip and gums. My mouth like it was burn inside. Upper lip was swollen every morning and then goes away throughout the day. My tongue was red and irritative. The symptoms did not respond to mouth, waste and antibiotics that was prescribed by the doctor. After a third visit to the doctor, they gave me a steroid that help but did not make it go completely away.
AFTER WAITING PER PROTOCOL FOR 15 MINUTES SHE THOUGHT HER THROAT TIGHTEND. ON SITE EMS RESPONDED. PER EMS HER THROAT APPEARED NORMAL UPON EXAM. HER VITALS ARE BELOW. SHE WAS OFFERED 25MG BENADRYL AND REFUSED. SHE WAS RELEASE TO HOME
History.  The patient came today at 4 years of age with his mother and 2 siblings who have similar symptoms with complaint of illness since yesterday.  Of note is the fact that the child received the FLUMIST vaccine on October 9 as did one of his siblings the other sibling having received the injectable flu vaccine.  All 3 children are now ill.  The patient has been very sleepy, anorexic.  He has not had any diarrhea or vomiting.  He was no ALBUTEROL for wheezing during infancy.  Exam.  Patient's weight is 32 pounds, temperature 101.8 degrees, pulse 108, respiratory rate is 20, and blood pressure is 80/58.  There are no meningeal signs.  Tympanic permits bilaterally are normal.  Examination the nose mouth and pharynx is unremarkable.  Auscultation of the chest revealed upper airway congestion sounds.  Heart sounds were normal without murmurs.  The abdomen was soft without organomegaly or masses.  Assessment.  Viral syndrome (probable influenza) Reaction to FLUMIST?  Plan.  I recommended to mother to begin NEBULIZER ALBUTEROL if chest congestion increases but it can also be done at this point.  I also recommended a trial of steam inhalation.  TYLENOL or ibuprofen can be used for her treatment of the fever.   If the child develops additional concerning symptoms they should be reevaluated.  Report will be submitted to VAERS.
Client was given a high dose flu shot today (11/7/23) after client received a high dose flu shot on 10/18/23.
Initially there was a small bruise and very mild tenderness at injection site (left deltoid). The bruise has gotten bigger , there is now a pea sized lump under the bruise and the area under the bruise has increased in tenderness to the point where it is not tender to very light touch. There is no redness, swelling  or discharge at the site.  I have been experiencing  a great deal of nausea since the second shot. No fevers.
Headache, chills took TYLENOL + was better 4-5 hrs. later.
Very tired with small headache on Jan 30.  Monday, Feb 1 awoke to a fib situation.  Went to ER and was cardioverted back to regular rhythm
Upon rising on 10/26/2019, I noticed my left shoulder had developed a circular patch of about 8" and crowning over and around the shoulder. The pain level is stable at 2-3 and feels to be in only the epidural area. This area has the feeling of tightness as in the use of "tough skin" used by sports players. To date, it gets no better or worse.
This spontaneous report as received from a registered pharmacist refers to a 62 years old female patient. The patient was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Lot # reported as 02557AE, exp 15-MAR-2013) on 23-OCT-2012. No other co-suspects were reported. Concomitant medications included: FLUVIRIN. The patient went to the pharmacy within less than 48 hours after vaccination with her arm being red, swollen and hard at the injection site. The patient also experienced burning. The patient was told to put an ice pack on her arm that had the swelling. No labs/diagnostic studies were performed. It was reported that the burning stopped but the redness and hardness were still there. The outcome for the swelling was not reported. The relatedness for the events was unknown for ZOSTAVAX. Additional information has been requested.
She was on the home from the vaccine and felt tightening of her face, and got home and looked in the mirror and her face was red.  She does have rosacea but this was worse.  After she got home she began to feel her heart beating rapidly.  She had taken her medications, but about 6:00 PM she took an extra dose of Metoprolol and waited until about 8:00 PM and the rapid heart beat was still there.  Her son took her BP and it was extremely high and it was 119/68, pulse 112.   At 11:00 her BP was 108/59 with a pulse of 78.   She was able to sleep but did feel heaviness the day later and rapid beating had subsided.   She is still having the rosacea, tingling, stinging of her face.  Her vaccine site was not even sore and he no problems with that.  She called her doctor and the nurse called her back, and she has been trying to call the place where she got the vaccine.  She was told to make sure what to do before she gets the 2nd shot.   She has recovered from the rapid heart beat episode, but the skin stinging of her face is still ongoing.
urticarial rash at the site of vaccination and at other sites including all extremities and trunk, followed by papular rash in clusters diffusely over body
fever to 102,inj site painful;treated in ER;parents told pt is allerg to tetramune